Breakthrough MS Treatment Shows Sustained Improvement in Vision and Cognition Over 35 Months |Rob Etherington, CEO, Clene Inc. 00:10:00

Share On Facebook Share On Twitter

A breakthrough MS treatment, CNM-Au8, demonstrates sustained improvement in vision and cognition over 35 months in a long-term study, presenting promising results for enhancing the quality of life for individuals with multiple sclerosis.

Recent Videos